Market tests biotech's health
Article Abstract:
The challenges facing Australian biotechnology firms are discussed. Many succeeded in raising funds in the second half of 2000, but those lacking the financial resources to meet the cost of existing projects will face significant difficulties in the current market.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
On the trail of the profitable proteins
Article Abstract:
Growth in the biotechnology market has been driven by the desire to understand and map human building materials, such as proteins and DNA, with many investors willing to back such companies in return for high dividends.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Big price, little value
Article Abstract:
Issues are presented concerning the 550-million Australian dollars issue valuation which has been placed on the biotechnology company Marshall Edwards Inc. The response of investors to the high valuation is discussed.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Miners' costs pose threat to contractors. Big names, big losses. Metals industry starts whispering the B word
- Abstracts: Marketing feats and flops - of 2000. Phone a friend
- Abstracts: Direct quotes on the building site, via laptop. LookSmart is looking better. Son of LookSmart takes up the retail trade
- Abstracts: The three Ms of customer loyalty. Growing up. The democratization of data
- Abstracts: The game gets tougher. Here comes the squeeze